- 专利标题： Crystalline hydrate of a JAK inhibitor compound
-
申请号： US17249375申请日： 2021-03-01
-
公开(公告)号： US11702415B2公开(公告)日： 2023-07-18
- 发明人: Gene Timothy Fass
- 申请人： THERAVANCE BIOPHARMA R&D IP, LLC
- 申请人地址： US CA South San Francisco
- 专利权人： Theravance Biopharma R&D IP, LLC
- 当前专利权人： Theravance Biopharma R&D IP, LLC
- 当前专利权人地址： US CA South San Francisco
- 代理机构： Sheppard Mullin Richter & Hampton LLP
- 主分类号： C07D471/04
- IPC分类号： C07D471/04 ; A61P11/06 ; A61K9/00
摘要：
Provided herein is a crystalline hydrate of the compound of formula 1:
Also provides herein are pharmaceutical compositions comprising such crystalline hydrate, methods of using such crystalline hydrate to treat respiratory diseases, and processes useful for preparing such crystalline hydrate.
Also provides herein are pharmaceutical compositions comprising such crystalline hydrate, methods of using such crystalline hydrate to treat respiratory diseases, and processes useful for preparing such crystalline hydrate.
公开/授权文献
- US20210269437A1 CRYSTALLINE HYDRATE OF A JAK INHIBITOR COMPOUND 公开/授权日：2021-09-02
信息查询
